Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.7743 | 100 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.5937 | 100 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.7099 | 100 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.4942 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 13.748 | 100 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.7489 | 100 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.7184 | 100 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.8552 | 100 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.7775 | 100 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.7953 | 100 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 14.0018 | 100 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.8832 | 100 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.9889 | 100 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.91 | 100 |